1 |
Barry, B. W., Mode of action of penetration enhancers in human skin. J. Contr. Res., 6, 85-97 (1987)
DOI
ScienceOn
|
2 |
Green, P. G., Guy, R. H., and Hadgraft, J., In vitro and in vivo enhancement of skin permeation with oleic and lauric acids. Int. J. Pharm., 48, 103-111 (1988)
DOI
ScienceOn
|
3 |
Nokhodchi, A., Shokri, J., Dashbolaghi, A., Hassan-Zadeh, D., Ghafourian, T., and Barzegar-Jalali, M., The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm., 250, 359-369 (2003)
DOI
ScienceOn
|
4 |
Roy, S. D., Gutierrez, M, Flynn, G. L., and Cleary, G. W., Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design. J. Pharm. Sci., 85, 491-495 (1996)
DOI
ScienceOn
|
5 |
Yamada, M., Uda, Y., and Tanigawara, Y., Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull., 35, 3399-3406 (1987)
DOI
PUBMED
ScienceOn
|
6 |
Aungst, B. J., Blake, J. A., and Hussain, M. A., Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res., 7, 712-718 (1990)
DOI
ScienceOn
|
7 |
Butcher, M. E., Global experience with ondansetron and future potential. Oncology, 50, 191-197 (1993)
DOI
PUBMED
ScienceOn
|
8 |
Gwak, H. S., Oh, I. S., and Chun, I. K., Solubility and physicochemical stability of ondansetron hydrochloride in various vehicles. J. Kor. Pharm. Sci., 33, 45-49 (2003b)
|
9 |
Chien, Y. W. and Lambert, H. J., Controlled drug release from polymeric delivery devices II: differentiation between partition-controlled and matrix-controlled drug release mechanism. J. Pharm. Sci., 63, 515-519 (1974)
DOI
PUBMED
|
10 |
Blackwell, C. P. and Harding, S. M., The clinical pharmacology of ondansetron. Eur. J. Cancer Clin. Oncol., 25 (Suppl 1), S21-S24 (1989)
PUBMED
|
11 |
Gwak, H. S., Oh, I. S., and Chun, I. K., Transdermal delivery of ondansetron hydrochloride: effect of vehicles and penetration enhancers. Drug Dev. Ind. Pharm., accepted (2003a)
|
12 |
Hesketh, P. J. and Gandara, D. R., Serotonin antagonists: a new class of antiemetic agents. J. Natl. Cancer Inst., 83, 613-620 (1991)
DOI
PUBMED
|
13 |
Mllgard, B. and Hoelgaard, A., Vehicle effect in topical drug delivery I. Influence of glycols and drug concentration on skin transport. Acta. Pharm. Suec., 20, 433-442 (1983)
PUBMED
|
14 |
Cho, Y. J. and Choi, H. K., Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm.,169, 95-104 (1998)
DOI
ScienceOn
|
15 |
Gwak, H. S. and Chun, I. K., Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm., 236, 57-64 (2002)
DOI
PUBMED
ScienceOn
|
16 |
McKenzie, R., Kovac, A., O'Connor, T., Duncalf, D., Angel, J., Gratz, I., Tolpin, E., McLeskey, C., and Joslyn, A., Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology, 78, 21-28 (1993)
DOI
PUBMED
ScienceOn
|
17 |
Santoyo, S., Arellano, A., Ygartua, P., and Martin, C., Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int. J. Pharm., 117, 219-224 (1995)
DOI
ScienceOn
|
18 |
Gwak, H. S., Kim, S. U., and Chun, I. K., Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. Arch. Pharm. Res., 25, 392-396 (2002)
DOI
ScienceOn
|
19 |
Scuderi, P., Wetchler, B., Sung, Y. F., Mingus, M., DuPen, S., Claybon, L., Leslie, J., Talke, P., Apfelbaum, J., and Sharifi-Azad, S., Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology, 78, 15-20 (1993)
DOI
PUBMED
ScienceOn
|